Gujarat Kidney & Super Speciality Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|
| Revenue | 9.79 | 9.66 | 11.45 |
| Operating Expense | 5.62 | 5.55 | 5.12 |
| Net Profit | 2.33 | 2.30 | 3.90 |
| Net Profit Margin | 23.80 | 23.81 | 34.06 |
| Earning Per Share | 0.41 | 0.40 | 0.69 |
| EBIDTA | 4.20 | 4.14 | 6.38 |
| Effective Tax Rate | 20.62 | 20.92 | 24.49 |
| Particulars | Dec 2025 |
|---|---|
| Revenue | 9.79 |
| Operating Expense | 5.62 |
| Net Profit | 2.33 |
| Net Profit Margin | 23.80 |
| Earning Per Share | 0.41 |
| EBIDTA | 4.20 |
| Effective Tax Rate | 20.62 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 |
|---|---|---|
| Total Revenue Annual | 4.98 | TBA |
| Operating Expenses Annual | 3.42 | 0.01 |
| Operating Profit Annual | 2.26 | -0.01 |
| Interest Annual | 0.04 | TBA |
| Depreciation | 0.28 | TBA |
| Net Profit Annual | 1.45 | -0.01 |
| Tax Annual | 0.49 | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 4.98 |
| Operating Expenses Annual | 3.42 |
| Operating Profit Annual | 2.26 |
| Interest Annual | 0.04 |
| Depreciation | 0.28 |
| Net Profit Annual | 1.45 |
| Tax Annual | 0.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 |
|---|---|---|
| Cash Flow at the Beginning | TBA | TBA |
| Cash Flow from Operations | -2.11 | TBA |
| Cash Flow from Investing | -7.35 | TBA |
| Cash Flow from Financing | 10.63 | TBA |
| Cash Flow at the End | 1.18 | TBA |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | TBA |
| Cash Flow from Operations | -2.11 |
| Cash Flow from Investing | -7.35 |
| Cash Flow from Financing | 10.63 |
| Cash Flow at the End | 1.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 |
|---|---|---|
| PBDIT Margin (%) | 31.53 | TBA |
| PBIT Margin (%) | 25.90 | TBA |
| PBT Margin (%) | -616.67 | TBA |
| Net PROFIT Margin (%) | 29.12 | TBA |
| Return On Networth / Equity (%) | 16.70 | -2.70 |
| Return On Networth /Employed (%) | 19.02 | -2.70 |
| Return On Assets (%) | 21.55 | TBA |
| Total Debt / Equity (X) | 0.17 | TBA |
| Asset Turnover Ratio (%) | 0.74 | TBA |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 31.53 |
| PBIT Margin (%) | 25.90 |
| PBT Margin (%) | -616.67 |
| Net PROFIT Margin (%) | 29.12 |
| Return On Networth / Equity (%) | 16.70 |
| Return On Networth /Employed (%) | 19.02 |
| Return On Assets (%) | 21.55 |
| Total Debt / Equity (X) | 0.17 |
| Asset Turnover Ratio (%) | 0.74 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 |
|---|---|---|
| Fixed Assets Annual | 9.74 | 2.67 |
| Total Current Assets Annual | 6.81 | 1.15 |
| Non Current Assets Annual | 10.01 | 2.72 |
| Total Shareholders Funds Annual | 10.89 | 0.37 |
| Total Assets Annual | 16.82 | 3.87 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 9.74 |
| Total Current Assets Annual | 6.81 |
| Non Current Assets Annual | 10.01 |
| Total Shareholders Funds Annual | 10.89 |
| Total Assets Annual | 16.82 |
EPS (INR)
Expected
0.52
Reported
0.52
Surprise
0.00%
Sep 2025
EPS beaten by 0.00%
Jun 2025
EPS beaten by 0.00%
Mar 2025
EPS beaten by 0.00%
